These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33593109)

  • 1. Dysregulation of brain dopamine systems in major depressive disorder.
    Delva NC; Stanwood GD
    Exp Biol Med (Maywood); 2021 May; 246(9):1084-1093. PubMed ID: 33593109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine dysregulation hypothesis: the common basis for motivational anhedonia in major depressive disorder and schizophrenia?
    Szczypiński JJ; Gola M
    Rev Neurosci; 2018 Sep; 29(7):727-744. PubMed ID: 29573379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine System Dysregulation in Major Depressive Disorders.
    Belujon P; Grace AA
    Int J Neuropsychopharmacol; 2017 Dec; 20(12):1036-1046. PubMed ID: 29106542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular network of neuronal autophagy in the pathophysiology and treatment of depression.
    Jia J; Le W
    Neurosci Bull; 2015 Aug; 31(4):427-34. PubMed ID: 26254058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Striatal Dopamine Transporter Binding in Individuals With Major Depressive Disorder: In Vivo Positron Emission Tomography and Postmortem Evidence.
    Pizzagalli DA; Berretta S; Wooten D; Goer F; Pilobello KT; Kumar P; Murray L; Beltzer M; Boyer-Boiteau A; Alpert N; El Fakhri G; Mechawar N; Vitaliano G; Turecki G; Normandin M
    JAMA Psychiatry; 2019 Aug; 76(8):854-861. PubMed ID: 31042280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a history of major depressive disorder on smoking-induced dopamine release.
    Brody AL; Olmstead RE; Abrams AL; Costello MR; Khan A; Kozman D; Saxena S; Farahi J; London ED; Mandelkern MA
    Biol Psychiatry; 2009 Nov; 66(9):898-901. PubMed ID: 19640507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute anxiety disorder, major depressive disorder, bipolar disorder and schizophrenia are related to different patterns of nigrostriatal and mesolimbic dopamine dysfunction.
    Nikolaus S; Mamlins E; Hautzel H; Müller HW
    Rev Neurosci; 2019 May; 30(4):381-426. PubMed ID: 30269107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential roles for opioid receptors in motivation and major depressive disorder.
    Callaghan CK; Rouine J; O'Mara SM
    Prog Brain Res; 2018; 239():89-119. PubMed ID: 30314570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe.
    Tremblay LK; Naranjo CA; Graham SJ; Herrmann N; Mayberg HS; Hevenor S; Busto UE
    Arch Gen Psychiatry; 2005 Nov; 62(11):1228-36. PubMed ID: 16275810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects.
    Hasler G; Fromm S; Carlson PJ; Luckenbaugh DA; Waldeck T; Geraci M; Roiser JP; Neumeister A; Meyers N; Charney DS; Drevets WC
    Arch Gen Psychiatry; 2008 May; 65(5):521-31. PubMed ID: 18458204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine Release in Antidepressant-Naive Major Depressive Disorder: A Multimodal [
    Schneier FR; Slifstein M; Whitton AE; Pizzagalli DA; Reinen J; McGrath PJ; Iosifescu DV; Abi-Dargham A
    Biol Psychiatry; 2018 Oct; 84(8):563-573. PubMed ID: 30041971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal correlates of depression.
    Chaudhury D; Liu H; Han MH
    Cell Mol Life Sci; 2015 Dec; 72(24):4825-48. PubMed ID: 26542802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatments.
    Party H; Dujarrier C; Hébert M; Lenoir S; Martinez de Lizarrondo S; Delépée R; Fauchon C; Bouton MC; Obiang P; Godefroy O; Save E; Lecardeur L; Chabry J; Vivien D; Agin V
    Acta Neuropathol Commun; 2019 Oct; 7(1):153. PubMed ID: 31610810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is depression associated with dysfunction of the central reward system?
    Martin-Soelch C
    Biochem Soc Trans; 2009 Feb; 37(Pt 1):313-7. PubMed ID: 19143654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural energy computations based on Hodgkin-Huxley models bridge abnormal neuronal activities and energy consumption patterns of major depressive disorder.
    Li Y; Zhang B; Liu Z; Wang R
    Comput Biol Med; 2023 Nov; 166():107500. PubMed ID: 37797488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data?
    Puryear CB; Brooks J; Tan L; Smith K; Li Y; Cunningham J; Todtenkopf MS; Dean RL; Sanchez C
    Neurosci Biobehav Rev; 2020 Jan; 108():658-678. PubMed ID: 31821832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Proinflammatory Cytokines in Dopaminergic System Disturbances, Implications for Anhedonic Features of MDD.
    Pan Z; Rosenblat JD; Swardfager W; McIntyre RS
    Curr Pharm Des; 2017; 23(14):2065-2072. PubMed ID: 28078987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal dopamine D2/3 receptor-mediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response.
    Peciña M; Sikora M; Avery ET; Heffernan J; Peciña S; Mickey BJ; Zubieta JK
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):977-986. PubMed ID: 28870407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amygdala connectivity mediates the association between anxiety and depression in patients with major depressive disorder.
    He C; Gong L; Yin Y; Yuan Y; Zhang H; Lv L; Zhang X; Soares JC; Zhang H; Xie C; Zhang Z
    Brain Imaging Behav; 2019 Aug; 13(4):1146-1159. PubMed ID: 30054873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine Learning Identifies Large-Scale Reward-Related Activity Modulated by Dopaminergic Enhancement in Major Depression.
    Liu Y; Admon R; Mellem MS; Belleau EL; Kaiser RH; Clegg R; Beltzer M; Goer F; Vitaliano G; Ahammad P; Pizzagalli DA
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2020 Feb; 5(2):163-172. PubMed ID: 31784354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.